The drug is an A3 adenosine receptor agonist and sounds like the high dose induced desensitization of the receptor. I have no biological explanation to the too quick placebo response after crossover.
I know you cannot read Hebrew but you can see 'JP Morgan' in the 7th line in their PR here:
I suppose they will set meetings with potential investors there, so nothing you can listen to. Come over if you wanna have a sunny week plus a meeting with the company
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.